Company Haleon plc

Company Haleon plc

HLN

GB00BMX86B70

Pharmaceuticals

Analysts' Consensus

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Haleon plc

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Haleon plc

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:01 26/04/2024 pm IST			5-day change	1st Jan Change
334.4 ^GBX	+0.87%		+2.64%	+3.96%

25/04	Moody’s Affirms Haleon’s Ratings on Strong Operating Performance	MT
24/04	Haleon: a new CFO at the end of October	CF

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows:

- oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.;

- Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.;

- medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.;

- respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.;

- vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.

Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).

Number of employees: 25,408

GBP in Million	2022	Weight	2023	Weight	Delta
Oral Health 27.7 %	2,957	27.2 %	3,136	27.7 %	+6.05%
Pain Relief 23.5 %	2,551	23.5 %	2,652	23.5 %	+3.96%
Digestive Health and Other 18.9 %	2,096	19.3 %	2,138	18.9 %	+2.00%
Respiratory Health 15.4 %	1,579	14.5 %	1,736	15.4 %	+9.94%
Vitamins, Minerals and Supplements 14.5 %	1,675	15.4 %	1,640	14.5 %	-2.09%

GBP in Million	2022	Weight	2023	Weight	Delta
EMEA and Latin America 40.2 %	4,270	39.3 %	4,545	40.2 %	+6.44%
North America 37.1 %	4,116	37.9 %	4,195	37.1 %	+1.92%
APAC 22.7 %	2,472	22.8 %	2,562	22.7 %	+3.64%

Managers	Title	Age	Since
Brian McNamara CEO	Chief Executive Officer	57	22/21/22
Tobias Hestler DFI	Director of Finance/CFO	52	01/21/01
Franck Riot CTO	Chief Tech/Sci/R&D Officer	-	16/21/16
Sonya Ghobrial IRC	Investor Relations Contact	-	-
Tamara Rogers SAM	Sales & Marketing	-	16/21/16
Lisa Paley PRN	Corporate Officer/Principal	-	-
Keith Choy PRN	Corporate Officer/Principal	-	-
Filippo Lanzi PRN	Corporate Officer/Principal	-	-
Mairéad Nayager HRO	Human Resources Officer	-	01/22/01
Bjarne Tellmann LAW	General Counsel	57	16/21/16

Members of the board	Title	Age	Since
Bryan Supran BRD	Director/Board Member	-	18/22/18
Dame Cox BRD	Director/Board Member	63	18/22/18
Tracy Clarke BRD	Director/Board Member	57	18/22/18
Vindi Banga BRD	Director/Board Member	69	18/22/18
Deirdre Mahlan BRD	Director/Board Member	61	18/22/18
David Lewis CHM	Chairman	59	23/22/23
David Denton BRD	Director/Board Member	59	01/23/01
Tobias Hestler DFI	Director of Finance/CFO	52	01/21/01
Brian McNamara CEO	Chief Executive Officer	57	22/21/22
Marie-Anne Aymerich BRD	Director/Board Member	-	18/22/18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,132,301,104	7,072,820,336 ( 77.45 %)	0	77.45 %

Name	Equities	%	Valuation
PFIZER, INC. 32.36 %	2,955,063,626	32.36 %	12 435 M p
GSK PLC 4.219 %	385,320,110	4.219 %	1 621 M p
The Vanguard Group, Inc. 1.790 %	163,500,000	1.790 %	688 M p
Dodge & Cox 1.733 %	158,253,000	1.733 %	666 M p
Norges Bank Investment Management 1.621 %	148,004,000	1.621 %	623 M p
MFS International (UK) Ltd. 1.379 %	125,915,466	1.379 %	530 M p
GIC Pte Ltd. (Investment Management) 1.045 %	95,442,000	1.045 %	402 M p
BlackRock Advisors (UK) Ltd. 0.9963 %	90,981,000	0.9963 %	383 M p
BlackRock Investment Management (UK) Ltd. 0.7176 %	65,536,000	0.7176 %	276 M p
Royal London Asset Management Ltd. 0.5687 %	51,936,000	0.5687 %	219 M p

Name	Equities	%	Valuation
Dodge & Cox 2.424 %	110,663,098	2.424 %	940 M p
Fidelity Management & Research Co. LLC 1.399 %	63,897,244	1.399 %	542 M p
ClearBridge Investments LLC 0.5822 %	26,581,902	0.5822 %	226 M p
Harding Loevner LP 0.4900 %	22,372,190	0.4900 %	190 M p
Fisher Asset Management LLC 0.3228 %	14,737,776	0.3228 %	125 M p
Wellington Management Co. LLP 0.2966 %	13,542,346	0.2966 %	115 M p
AllianceBernstein LP 0.2396 %	10,939,898	0.2396 %	93 M p
Aristotle Capital Management LLC 0.1950 %	8,905,038	0.1950 %	76 M p
Merrill Lynch International 0.1843 %	8,414,511	0.1843 %	71 M p
Douglas Lane & Associates LLC 0.1840 %	8,401,876	0.1840 %	71 M p

Haleon Plc

The Heights Building 5, 1st Floor

KT13 0NY, Weybridge

+44 1932 822000

http://www.haleon.com

Name	Category and Sector
GlaxoSmithKline Consumer Pvt Ltd. GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The private company is based in Patiala, India and was founded in 2014.	Pharmaceuticals: Major
GlaxoSmithKline Consumer Healthcare Finance Ltd. GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the private company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare Holdings Ltd. GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The private company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014.	Financial Conglomerates
Haleon UK Trading Services Ltd. Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The private company is based in Weybridge, UK. Founded in 2012.	Drugstore Chains
GSK Consumer Healthcare Capital US LLC GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a private company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE.	Medical/Nursing Services
Haleon UK Capital Plc Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara.	Regional Banks
Gsk Consumer Healthcare Capital Nl BV Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The private company is located in the UK.	Pharmaceuticals: Other

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.344 GBP

Average target price

3.594 GBP

Spread / Average Target

+7.47%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
HALEON PLC	+3.96%	38.04B
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals